Skip to main content
Clinical Trials/NCT07618312
NCT07618312Not yet recruitingNot Applicable

Improving Patient Engagement in Mental Health Services: Adaptation and Implementation of a Behavioral Activation Intervention

Montana State University0 sites100 target enrollmentStarted: March 1, 2027Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100

Study Overview

Brief Summary

Hybrid Type II Implementation Trial

Detailed Description

The goal of this hybrid type II implementation trial is to test a telehealth behavioral activation intervention delivered in Spanish by community health workers in Spanish speakers living in rural and frontier areas of Montana and New Mexico. The main questions it aims to answer are:

Does an adapted behavioral activation intervention reduce depressive symptoms? Is engagement in the intervention the primary mechanism by which depressive scores are reduced?

Researchers will compare depressive symptoms in the intervention group as compared to a waitlisted group.

Participants will receive a weekly behavioral activation session via telehealth and will be asked to complete weekly surveys and homework. They will complete the Beck Depression Inventory (21 items) at baseline, after 12 weeks, and after 32 weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years or older
  • Spanish-speaking adult who prefers to receive services in Spanish
  • Resident of a rural or frontier community in Montana or New Mexico
  • Positive screen for depressive symptoms at or above study eligibility threshold on Spanish-language screening measure
  • Able and willing to participate in telehealth sessions
  • Able to provide informed consent

Exclusion Criteria

  • Active suicidal intent requiring immediate emergency intervention
  • Current psychosis or mania
  • Severe cognitive impairment that would prevent participation
  • Currently receiving intensive psychiatric treatment that would conflict with the intervention
  • Unable to participate in telehealth sessions
  • Unable to provide informed consent

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials